Background/Objectives: Folate and homocysteine have been implicated to have a role in depression. However, results of epidemiologic studies on this issue have been inconsistent. The objective of this study was to clarify the association between serum folate and homocysteine concentrations and depressive symptoms in Japanese adults. Subjects/Methods: We analyzed cross-sectional data for 530 municipal employees (313 men and 217 women), aged 21-67 years, who participated in a health survey at the time of periodic checkup. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. Logistic regression analysis was used to estimate odds ratios of depressive symptoms (CES-D scale scores of X16) with adjustment for potential confounding variables. Results: In total, 113 men (36.1%) and 79 women (36.4%) had depressive symptoms. A higher serum folate was associated with a decreased prevalence of depressive symptoms in men. The multivariate-adjusted odds ratios (95% confidence interval) of depressive symptoms for the lowest to highest quartiles of serum folate were 1.00 (reference), 0.53 (0.27-1.03), 0.33 (0.16-0.68) and 0.51 (0.25-1.03), respectively (trend P ¼ 0.03). Furthermore, the data suggested a positive association between serum homocysteine and depressive symptoms in men (trend P ¼ 0.06). In women, neither folate nor homocysteine was associated with depressive symptoms. Conclusions: Low serum folate may be related to an increased prevalence of depressive symptoms in Japanese men.
Introduction
Folate is involved in the metabolism of monoamines like serotonin in the brain (Bottiglieri, 2005; Reynolds, 2006) and thus may be related to mood disorder. The evidence of a role of folate in the development of depression was initially suggested by clinical observations that showed decreased levels of serum folate in depressed patients (Carney, 1967; Reynolds et al., 1970) . Administration of folic acid was also shown to be associated with early recovery from depression (Fava et al., 1997; Taylor et al., 2003) , suggesting a therapeutic importance of this nutrient. A protective role of folate in depression has been further supported by various epidemiologic studies, in which either dietary folate intake (Tolmunen et al., 2003 (Tolmunen et al., , 2004a Sanchez-Villegas et al., 2006; Murakami et al., 2008) or blood folate concentrations (Bjelland et al., 2003; Morris et al., 2003; Ramos et al., 2004; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008) or SNPs involved in folate metabolism (Gilbody et al., 2007a) was used as the exposure index. In a recent meta-analysis of 11 studies, persons with low levels of serum, low red blood cell or low intake of folate had a 1.4 times increased risk of depressive symptom, compared with those with high folate status (Gilbody et al., 2007b) . Higher homocysteine concentrations, a state suggestive of chronic folate deficiency, may also contribute to the pathogenesis of depression due to its potential toxicity to neurons and blood vessels (Bottiglieri, 2005; Reynolds, 2006) . Several epidemiologic studies (Bjelland et al., 2003; Tolmunen et al., 2004b; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008) have identified an increased prevalence of depressive state associated with high homocysteine concentrations.
In spite of the accumulating evidence to support a protective role of folate in depression, epidemiologic data about blood folate or homocysteine and depression are not entirely consistent; of eight studies that measured serum, plasma, or red blood cell folate concentrations (Penninx et al., 2000; Tiemeier et al., 2002; Bjelland et al., 2003; Morris et al., 2003; Ramos et al., 2004; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008) , two did not detect significant association (Penninx et al., 2000; Tiemeier et al., 2002) , and of nine studies that measured blood homocysteine concentrations (Penninx et al., 2000; Tiemeier et al., 2002; Bjelland et al., 2003; Morris et al., 2003; Tolmunen et al., 2004b; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008; Kamphuis et al., 2008) , four did not find an association (Penninx et al., 2000; Tiemeier et al., 2002; Morris et al., 2003; Kamphuis et al., 2008) . Moreover, the association between these substances in serum, plasma, or red blood cell and depression has been studied mainly among Western populations (Penninx et al., 2000; Tiemeier et al., 2002; Bjelland et al., 2003; Morris et al., 2003; Ramos et al., 2004; Tolmunen et al., 2004b; Sachdev et al., 2005; Dimopoulos et al., 2007; Kamphuis et al., 2008) but is limited among Asian populations (Kim et al., 2008) . Recently, we reported a lower prevalence of depressive symptoms associated with high folate intake among Japanese male employees (Murakami et al., 2008) . Here, we present the cross-sectional association of serum concentrations of folate and homocysteine with depressive symptoms.
Subjects and methods

Subjects
The subjects were participants in a health survey conducted in July and November 2006 among employees of two municipal offices in northeastern Kyushu, Japan. At the time of periodic health examination, all full-time workers (n ¼ 601) except those on long sick leave or maternity leave were invited. Of these, 547 subjects (323 men and 224 women aged 21-67 years) participated in the survey (response rate 91%). Participants were asked to fill in survey questionnaires beforehand, which were checked by research staff for completeness and, where necessary, clarified by asking the subject during the examination. Also obtained were data that were routinely collected in the health examination, including anthropometric measurements, biochemical data, and information about medical history, smoking and alcohol drinking. After exclusion of 17 subjects with missing information for any of the variables used in the main analysis, 530 workers (313 men and 217 women) remained for analysis. The protocol of the study was approved by the ethics committee of the International Medical Center of Japan, and written informed consent was obtained from each participant.
Serum folate and homocysteine
Venous blood (7 ml) was drawn in tube and then taken in a cooler box to a laboratory, where blood was centrifuged for 10 min and the serum was divided in a maximum of six tubes (0.5 ml each) within 4 h of blood drawing. Five of these tubes, excluding one for the analysis of fatty acid composition, were stored at À80 1C until analysis. Serum folate and homocysteine concentrations were measured at an external laboratory (Mitsubishi Chemical Medience, Tokyo, Japan) using a chemiluminescent immunoassay and a high-performance liquid chromatography.
Depressive symptoms
Depressive symptoms were assessed using the Japanese version (Shima et al., 1985) of the Center for Epidemiologic Studies Depression (CES-D) scale (Radloff, 1977) , which was incorporated into the lifestyle questionnaire. This scale consists of 20 questions addressing six symptoms of depression, including depressed mood, guilt or worthlessness, helplessness or hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance experienced during the preceding week. Each question is scored on a scale of 0-3 according to the frequency of the symptom, and the total CES-D score ranges from 0 to 60. The criterion validity of the CES-D scale has been well established both in Western (Radloff, 1977) and Japanese (Shima et al., 1985) subjects. Depressive symptoms were defined as present when subjects had a CES-D score of X16. Other cutoff values for the definition were also used: X19 that may be suitable for Japanese (Wada et al., 2007) and X23 indicative of severe depressive state (Wada et al., 2007) .
Assessment of diet
Dietary habits during the preceding month were assessed using a validated brief self-administered diet history questionnaire (BDHQ) (Sasaki, 2004) , which contains queries about the consumption frequency of 56 foods and beverages commonly consumed in general Japanese populations. Dietary intake for energy and selected nutrients were estimated using an ad hoc computer algorithm for the BDHQ, with reference to the Standard Tables of Food Composition in Japan (Science and Technology, 2005a, b) . Because few subjects took dietary supplements on weekly basis (multivitamins 3.7%, vitamin D 0.2% and multiminerals 1.1%), dietary supplement was not incorporated into the analysis. According to the validation study of the BDHQ using 16-day weighed dietary records as the gold standard, Pearson's correlation coefficients for folate intake in 92 men and 92 women of 31-76 years were 0.50 and 0.62, respectively (Sasaki, 2004) .
Other variables
Marital status, job title, job position and non-job physical activity were asked in the survey questionnaire. Job title was used to create categories for occupational physical activity; sedentary work: managerial and clerical jobs; physically active work: child-care, school lunch cooking and technical jobs. Non-job physical activity was asked for daily minutes spent for walking or cycling during commute to or from work and weekly hours engaged in each of five different activities in leisure (walking, low-, moderate-and highintensity activities, and gardening). The sum of time spent for all the non-job activities or that for leisure time activity was expressed in hours per week.
Statistical analysis
Differences in the characteristics between subjects with and without depressive symptoms were assessed by using independent t-test (continuous variable) and w 2 -test (categorical variable). Participants were divided into quartiles of serum folate or homocysteine concentrations. To examine the association between serum folate or homocysteine and depressive symptoms, we performed multiple logistic regression analysis and calculated the odds ratios and 95% CIs of depressive symptoms for the quartiles of serum folate or homocysteine concentrations, taking the lowest quartile category as reference. The first model was adjusted for age (year, continuous) and workplace (A or B) , and the second model was further adjusted for marital status (married or unmarried), job position (low, middle or high for men and low or middle þ high for women), occupational physical activity (sedentary or active work), leisure-time physical activity (0, 0o-o 5 or X5 metabolic equivalent-hour per week), current smoking (yes or no) and alcohol consumption (nondrinker or drinker with a consumption of o20 or X20 g of ethanol per day). Trend of the association was assessed using multiple linear regression analysis, with ordinal numbers 0-3 assigned to the quartile categories of serum folate or homocysteine. Two-sided P-values of less than 0.05 were regarded as statistically significant. All analyses were performed with Statistical Analysis System (SAS) software version 9.1 (SAS Institute, Cary, NC, USA).
Results
The characteristics of study subjects are shown in Table 1 . In total, 113 men (36.1%) and 79 women (36.4%) were identified as having depressive symptoms (CES-D scale scores of X16). The prevalence of those with a CES-D scale scores of X19 and X23 were 25.9 and 14.4% in men and 26.7 and 14.3% in women, respectively. Compared with men without depressive symptoms, men with depressive symptoms were more likely to be unmarried and less likely to be in high-job position, and they consumed less amount of folate. Women with depressive symptoms were more likely to be engaged in sedentary work than women without the symptoms. The odds ratios of depressive symptoms according to quartile categories of serum folate concentrations are shown in Table 2 . A higher serum folate concentration was associated with a decreased prevalence of depressive symptoms in men but not in women. In men, multivariateadjusted odds ratios of having depressive symptoms were approximately 50-70% lower in the upper three quartiles of serum folate than in the lowest quartile. The inverse association was more evident when a higher cutoff (CES-D scale score of X19), which may be more suitable for Japanese, was used (trend P ¼ 0.003). Odds ratios of severe depressive state (CES-D scale score of X23) were similarly decreased in groups of higher folate status. Additional adjustment of serum homocysteine did not alter these results (data not shown). Among women, there was no association between serum folate and depressive symptom.
As shown in Table 3 , the prevalence of depressive symptoms tended to increase with serum homocysteine concentrations in men; multivariate-adjusted odds ratios (95% CI) of depressive symptoms for the second, third and fourth quartiles versus the lowest quartile were 0.89 (0.44-1.81), 1.56 (0.78-3.12) and 1.69 (0.83-3.42), respectively (trend P ¼ 0.06). The odds ratios did not change materially when a higher cutoff point (CES-D scale score of X19) was used in the definition of depressive symptoms. Severe depressive symptoms (CES-D scale score of X23) were not related to serum homocysteine concentrations. Additional adjustment of serum folate did not materially change these results, although the association was somewhat attenuated. Serum homocysteine was not related to depressive symptoms in women.
Discussion
In this cross-sectional study of Japanese men and women using serum samples, we found a decreased prevalence of depressive symptoms associated with higher folate concentrations in men. There was also a suggestion of an increasing prevalence of depressive symptoms with homocysteine concentrations in men. In women, neither folate nor homocysteine was associated with depressive symptoms. To the best of our knowledge, this is the second study to report depressive symptoms in association with blood folate or homocysteine among Asian populations.
The protective association between serum folate and depressive symptoms in this study has been observed in many (Bjelland et al., 2003; Morris et al., 2003; Ramos et al., 2004; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008) , but not all (Penninx et al., 2000; Tiemeier et al., 2002) studies. The association was consistently found among populations with an average age of less than 70 years (Bjelland et al., 2003; Morris et al., 2003; Sachdev et al., 2005; Dimopoulos et al., 2007) . However, of four studies among elderly population with an average of 70 years and above (Penninx et al., 2000; Tiemeier et al., 2002; Ramos et al., 2004; Kim et al., 2008) , two failed to detect an association with serum folate (Penninx et al., 2000; Tiemeier et al., 2002) . Similarly, Bjelland et al. (2003) , who found a protective association between serum folate and depressive symptoms among middle-aged women (aged 46-49 years), failed to observe any relation among elderly women (aged 70-74 years). Depressive symptoms in the elderly are more likely to be caused by serious diseases, including cancer, cerebrovascular disease, chronic medical illness, complication, cognitive impairment and disability (Alexopoulos, 2005) , thus making it difficult to find an association with blood folate.
We previously reported a similar inverse association between dietary folate intake and depressive symptoms in men of the same study population (Murakami et al., 2008) ; the multivariate-adjusted odds ratios of depressive symptoms for men in the lowest through highest quartiles of folate intake were 1.00 (reference), 0.78 (0.38-1.63), 0.57 (0.27-1.18) and 0.50 (0.23-1.06), respectively (trend P ¼ 0.045). It should be noted that serum folate concentrations and dietary folate intake were only modestly correlated with each other (Spearman's rank correlation coefficient; 0.21 for men and 0.13 for women). This may be partly accounted for by reporting bias in dietary survey but other factors including cooking method (McKillop et al., 2002) and genetic factor (Bottiglieri, 2005; Gilbody et al., 2007a) should also influence. Specifically, methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism (Bottiglieri, 2005; Gilbody et al., 2007a) , Serum folate, homocysteine and depression A Nanri et al and those carrying MTHFR 677TT genotype have a lower serum folate compared with those carrying 677CC genotype independent of folate intake (Nishio et al., 2008) . Studies based on dietary survey and those using serum sample have their own strengths and limitations, and thus our findings in men showing a protective association of depressive symptoms with both measures of folate lend a strong support to the hypothesis that folate is involved in depression.
We found a suggestion of a positive association between serum homocysteine and depressive symptoms in men. In the literature, their association has been inconsistent. Of nine studies, five observed an increased prevalence of depressive symptoms associated with a higher blood homocysteine concentration (Bjelland et al., 2003; Tolmunen et al., 2004b; Sachdev et al., 2005; Dimopoulos et al., 2007; Kim et al., 2008) , but the others found no association (Penninx et al., 2000; Tiemeier et al., 2002; Morris et al., 2003; Kamphuis et al., 2008 ). There are a few possible reasons for the inconsistency. First, similar to studies showing no association with serum, plasma or red blood cell folate, the average age of subjects in three (Penninx et al., 2000; Tiemeier et al., 2002; Kamphuis et al., 2008) of the four studies with null finding exceeded 70 years. We thus infer that the association between homocysteine and depressive symptoms among the elderly may be lessened by serious diseases, which may have an adverse effect on mood. Alternatively, the inconsistency may be attributed to the difference in the assessment of depression symptom. However, study result did not depend on diagnostic tool CES-D (Tiemeier et al., 2002; Ramos et al., 2004; Murakami et al., 2008) , Geriatric Depression Scale (Penninx et al., 2000; Dimopoulos et al., 2007) , Hospital Anxiety and Depression scale (Bjelland et al., 2003) and diagnostic interview schedule (Morris et al., 2003) , suggesting that this explanation is unlikely.
In this study, there was no association of serum folate or homocysteine with depressive symptoms in women. Although the reason is unclear, it may be partly ascribed to the fact that women had a much higher mean of serum folate concentrations than men (women, 5.2 ± 2.8 ng/ml; men, 3.8±1.9 ng/ml), whereas the opposite was observed for homocysteine (women, 8.4±2.6 nmol/ml; men, 13.0 ± 5.7 nmol/ml). Such a favorable profile of these substances in women may make it difficult to detect an association among them. The mechanism linking folate and homocysteine to depressive symptoms is unclear, but followings are suggested: 5-methyltetrahydrofolate is required in the synthesis of methionine from homocysteine; methionine is a precursor of S-adenosylmethionine, the methyl donor in many methylation reactions in the brain involving neurotransmitters, nucleic acids, proteins and phospholipids (Bottiglieri, 2005; Reynolds, 2006) . S-adenosylmethionine itself has also antidepressant properties (Bottiglieri, 2005; Reynolds, 2006) . Moreover, folate may protect brain function by decreasing homocysteine, which has a neurotoxic effect through several mechanisms, including impaired methylation, excitotoxicity, oxidative stress and hypoxia in the central nervous system (Bottiglieri, 2005) .
Major strengths of this study include high study participation rate and adjustment of known and suspected risk factor of depressive symptoms. Because this study was conducted in selected municipal offices at the time of the nonselective recruitment for the annual health checkup and high study participation rate (91%), the possibility of selection bias is low. In addition, smoking, alcohol consumption, physical activity, marital status and job position are suspected of being associated with the risk of depressive symptoms (Golding et al., 1990; Kawakami et al., 1990; Perez-Stable et al., 1990; Strawbridge et al., 2002; Lam et al., 2004; Inaba et al., 2005) , and we adjusted for these important confounding variables. This study had also some limitations. First, an association derived from cross-sectional study does not necessarily indicate causality. Specifically, lower serum folate concentration may be caused by loss of appetite as a result of depressive symptoms. However, this is not plausible because total energy intake was similar between subjects with and without depressive symptoms (Table 1) . Second, we measured serum concentrations of folate and homocysteine only at one point in time, which may not reflect long-term status. In particular, blood folate levels fluctuate depending on recent dietary intake. A study using a stable biomarker of folate status like red blood cell folate may show a clearer association. Finally, because study subjects were employees of municipal offices in Japan, the present findings may not be generalized to the population with a different background.
In a cross-sectional study of Japanese employees, higher serum folate concentrations were associated with a decreased prevalence of depressive symptoms in men. There was also a suggestion of a positive association between homocysteine concentrations and depressive symptoms in men. This result, together with similar findings from several studies, suggests that higher serum folate and, to lesser extent, lower serum homocysteine may contribute to the prevention of depressive symptoms. However, because most studies so far, including ours, were cross-sectional, the relation of folate and homocysteine to depressive symptoms requires confirmation in prospective studies.
